0
0
IL-6 Receptor Antagonists Improve COVID-19 Critical Care Outcomes at 6 Months - Pulmonology Advisor
1/31/23 at 12:43pm
Organization
Pulmonologyadvisor.com
Author
Sheila Jacobs
38 words
0
Comments
A secondary analysis of the REMAP-CAP trial evaluated long-term outcomes of multiple interventions used for critically ill patients with COVID-19.
You are the first to view
https://www.pulmonologyadvisor.com/home/topics/critical-care/il-6-receptor-antagonists-improve-covid-19-critical-care-outcomes-at-6-months/
Create an account or login to join the discussion